New Treatment For Food Poisoning

11 May 2006 --- The group has shown that one particular antibiotic – fosfomycin – can treat Listeria in the body, despite it being ineffective in laboratory conditions.

11/05/06 A team of researchers working at the University of Bristol has found a potential new treatment for listeriosis, a deadly form of food poisoning. Their work is reported in Nature Medicine.

The group, led by Professor Jose Vazquez-Boland, has shown that one particular antibiotic –  fosfomycin – can treat Listeria in the body, despite it being ineffective in laboratory conditions.

Because it was not effective in the laboratory, this drug has never been considered for the treatment of listeriosis, in spite of it reaching the infection sites more effectively than other antibiotics.

Professor Vazquez-Boland said: “Our results illustrate that antibiotic resistance in the laboratory does not always mean that the drug will not work in the infected patient. This work brings some optimism to the highly worrying problem of the increasing resistance to antibiotics.”

The Listeria bacteria causes the food-borne disease, listeriosis. It often triggers a brain infection and kills up to 30% of those affected.

To test whether antibiotics are effective, bacteria are taken from patients and tested in the laboratory. These tests measure whether antibiotics can halt the growth of Listeria in laboratory conditions. Such tests are usually a measure of how effective the drug will be in the body.

When tested this way, Listeria had been shown to be resistant to the antibiotic, fosfomycin. As a consequence, this drug has never been considered for the treatment of listeriosis.

Dr Mariela Scortti, lead author on the paper, added: “Our findings warn about the need to revise laboratory methods currently in use to determine the susceptibility or resistance of bacteria to such drugs, so that the tests reflect better what actually happens in the body.”

Related Articles

Nutrition & Health News

Four claims in one vegan capsule: Polaris to launch algal DHA omega 3 in softgel at FiE

21 Nov 2017 --- Polaris is launching its ultra-stable algal DHA omega 3 in vegan softgel format at Food Ingredients Europe, enabling it to offer four EFSA claims in one capsule, the company reports. Each capsule is said to deliver an optimal 250mg of DHA omega 3 from microalgae in a 100 percent plant-based shell, making it the ideal solution for consumers seeking a vegan or vegetarian alternative to gelatin capsules.

Nutrition & Health News

Recovery top of mind for FrieslandCampina as it assists Olympic athletes

20 Nov 2017 --- The focus on recovery is a hot topic in the world of sports nutrition. Its benefits may run deeper than many realize: René Kleinsmit, Product Group Manager at FrieslandCampina DMV, notes during a webinar hosted by NutritionInsight’s sister website FoodIngredientsFirst that those at the company talk about “recovery” when they actually mean “grow” or “build.” Topics important to the company therefore include optimal recovery times and muscle-building benefits, even while sleeping.

Nutrition & Health News

Gut bacteria sensitive to salt, linked to MS and hypertension: study

20 Nov 2017 --- Common salt reduces the number of certain lactic acid bacteria in the gut of mice and humans. This is according to a study published in the journal Nature by Berlin's Max Delbrück Center and Charité, which further notes an impact on immune cells that are partly responsible for autoimmune diseases like multiple sclerosis (MS) and hypertension. Probiotics were also found to ameliorate the symptoms of disease in mice.

Nutrition & Health News

Weight management – Keeping the kilos off (Part 3): Trends, innovation and strong opinions

17 Oct 2017 --- Weight management is a hot topic in the nutrition industry, and NutritionInsight has solicited the views of medical professionals and industry insiders on the next steps to take. Today, in the final part of a special report, we share the trends in the industry, some new R&D and expert opinions in the space in general.

Nutrition & Health News

BASF Newtrition Omega-3 launches Accelon absorption-accelerating technology

17 Nov 2017 --- Newtrition Omega-3 has announced the global launch of Accelon, an omega 3 absorption-accelerating technology that the company says has the potential to be the biggest category innovation since the introduction of high-concentrate omega 3s in the late 1980s.

More Articles
URL : http://www.nutritioninsight.com:80/news/New-Treatment-For-Food-Poisoning.html